WILMINGTON, Mass., Feb. 5 CardioTechInternational, Inc. (Amex: CTE), a developer and manufacturer of advancedmaterials and medical devices for the treatment of cardiovascular and otherdiseases, announced today that it will release its fiscal 2008 third quarterfinancial results before the market opens on Tuesday, February 12, 2008.Following the release, the Company will host a conference call for investorsat 2:30 p.m. ET (11:30 a.m. PT) to discuss its fiscal third quarter resultsand recent developments.
Participants should dial-in (866) 802-4355 Conference ID# 1191648 or (703)639-1323 outside the U.S. Please dial-in 10 minutes before the call isscheduled to begin. A replay of the call will be available for two weeksfollowing the call at (888)-266-2081 ID# 1191648 and on the Company's website.
About CardioTech International:
CardioTech is a developer of advanced polymer materials and manufacturerof medical products for the treatment and diagnosis of a broad range ofdisease states. The Company's business model leverages its proprietarymaterials science technology and manufacturing expertise in order to expandits product sales and royalty and license fee income. It develops nextgeneration polymers and manufactures new and complex medical devices tocustomers' unique specifications. CardioTech is conducting its first clinicaltrial for regulatory approval in Europe for its CardioPass synthetic coronarybypass graft. More information about CardioTech is available at its website:http://www.cardiotech-inc.com.For Further Information Contact: Eric Walters Vice President & Chief Financial Officer CardioTech International, Inc. 978-657-0075 email@example.com Sylvia Dresner Senior Vice President VMW Corporate & Investor Relations 212-616-6161 firstname.lastname@example.org
SOURCE CardioTech International, Inc.